Diagnosis and management of posttraumatic stress disorder in returning veterans

Journal of the American Osteopathic Association

Volumn 107, Issue 5, 2007, Pages 181-190

  Reeves, Roy R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; AMITRIPTYLINE; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE MALEATE; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; LITHIUM CARBONATE; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; PAROXETINE; PHENELZINE; PLACEBO; PRAZOSIN; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ACUTE STRESS DISORDER; ARMY; ATAXIA; AUTHORITY; BRADYCARDIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONFUSION; DIAGNOSTIC ERROR; DIZZINESS; DROWSINESS; DRUG APPROVAL; FATIGUE; HEADACHE; HEALTH; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPOTENSION; INSOMNIA; IRAQ; LOOSE FECES; LOW DRUG DOSE; MENTAL DISEASE; NAUSEA; PATIENT REFERRAL; PHYSICIAN; POSTTRAUMATIC STRESS DISORDER; PSYCHOEDUCATION; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; PUBLIC HEALTH; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SOLDIER; STRESS; UNITED STATES; VETERAN; WAR; WEAKNESS; WEIGHT GAIN; XEROSTOMIA;

ADRENERGIC ANTAGONISTS; AFGHANISTAN; ANTIDEPRESSIVE AGENTS; HUMANS; IRAQ; MILITARY MEDICINE; PRIMARY HEALTH CARE; PSYCHOTHERAPY; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; UNITED STATES; VETERANS; WAR;

EID: 34347333544     PISSN: 00986151     EISSN: 00986151     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Magruder KM, Frueh BC, Knapp RG, Davis L, Hamner MB, Martin RH, et al. Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2005;27:169-179.
2. Litz B, Orsillo SM. The returning veteran of the Iraq War: background issues and assessment guidelines. In: Iraq War Clinician Guide. 2nd ed. White River Station, Vt: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs; 2004:21-32. Available at: http://www.ncptsd.va. gov /ncmain/ncdocs/manuals/iraq_clinician_guide_ch_3.pdf. Accessed April 13, 2007.
3. Montagne R, Hammes T. Italian's death and rules of engagement in Iraq [interview]. Morning Edition. Washington DC: National Public Radio. March 9, 2005. Available at: http://www.npr.org/templates/story/story.php?storyId= 4527852. Accessed May 30, 2007.
4. Echevarria AJ II. Globalization and the Nature of War. Carlisle, Pa: Strategic War Studies Institute, US Army War College; 2003. Available at: http://www.strategicstudiesinstitute.army.mil/pdffiles/PUB215.pdf. Accessed May 30, 2007.
5. Kang HK, Natelson BH, Mahan CM, Lee KY, Murphy FM. Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population-based survey of 30,000 veterans. Am J Epidemiol. 2003;157:141-148. Available at: http://aje.oxfordjournals.org/cgi/content /full/157/2/141. Accessed April 13, 2007.
6. Hoge CW, Castro CA, Messer SC, McGurk DM, Cotting, DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Eng J Med. 2004;351:13-22.
7. Cozza SJ, Benedek DM, Bradley JC, Grieger TA, Nam TS, Waldrep DA. Topics specific to the psychiatric treatment of military personnel. In: Iraq War Clinician Guide. 2nd ed. White River Station, Vt: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs; 2004:4-20. Available at: http://www.ncptsd.va.gov/ncmain/ncdocs/manuals/ iraq_clinician_guide_ch_2.pdf. Accessed April 13, 2007.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: American Psychiatric Press: 2000:463-468.
9. Prins A, Kimerling R, Leskin G. PTSD in Iraq War veterans: implications for primary care. In: Iraq War Clinician Guide. 2nd ed. White River Station, Vt: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs; 2004:58-61. Available at: http://www.ncptsd.va.gov/ncmain/ ncdocs/manuals/ iraq_clinician_guide_ch_7.pdf. Accessed April 13, 2007.
10. Ruzek JI, Curran E, Friedman MJ, Gusman FD, Southwick SM, Swales P, et al. Treatment of the returning Iraq War veteran. In: Iraq War Clinician Guide. 2nd ed. White River Station, Vt: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs; 2004:33-45. Available at: http://www.ncptsd.va.gov/ncmain/ncdocs/manuals/iraq_clinician_guide_ch_4.pd. Accessed April 13, 2007.
11. Foa EB, Keane TM, Friedman MJ. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. New York, NY: Guilford Press; 2000.
12. Schoenfeld FB, Marmar CR, Neylan TC. Current concepts in pharmacotherapy for posttraumatic stress disorder. Psychiatr Serv. 2004;55:519-531. Available at: http://ps.psychiatryonline.org/cgi/content/full/55/5/519. Accessed April 13, 2007.
13. Ursano RJ, Bell C, Eth S, Freidman M, Norwood A, Pfefferbaum B, et al. Practice guidelines for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry. 2004;161(suppl 11):3-31. Available at: http://www.psych.org/psych_pract/treatg/pg/PTSD-PG-PartsA-B-C- New. pdf. Accessed April 13, 2007.
14. Asnis GM, Kohn SR, Henderson M, Brown NL. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations. Drugs. 2004;64:383-404.
15. Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. J Clin Psychiatry. 2006;67:1522-1526.
16. Davidson J, Kudler H, Smith R, Mahorney SL, Lipper S, Hammett E, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47:259-266.
17. Frank JB, Kosten T, Giller EL Jr, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. Am J Psychiatry. 1988;145:1289-1291.
18. Reist C, Kauffmann CD, Haier RJ, Sangdahl C, DeMet EM, Chicz-DeMet A, et al. A controlled trial of desipramine in 18 men with posttraumatic stress disorder. Am J Psychiatry. 1989;146:513-516.
19. Southwick SM, Yehuda R, Giller E, Charney ES. Use of tricyclics and monoamine oxidase inhibitors in the treatment of PTSD: a quantitative review. In: Marburg MM, ed. Catecholamine Function in Posttraumatic Stress Disorder: Emerging Concepts. Washington, DC: American Psychiatric Press; 1994.
20. Neal LA, Shapland W, Fox C. An open trial of moclobemide in the treatment of post-traumatic stress disorder. Int Clin Psychopharmacol. 1997;12:231-237.
21. Hidalgo R, Hertzberg MA, Mellman T, Petty F, Tucker P, Weisler R, et al. Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol. 1999;14:61-68.
22. Jody DM. Important drug warning including black box information: Serzone [US Food and Drug Administration Web site]. 2001. Available at: http://www.fda.gov/medwatch/SAFETY/2002/serzone_deardoc.PDF. Accessed April 13, 2007.
23. Davidson J, Baldwin D, Stein DJ, Kuper E, Benattia I, Ahmed S, et al. Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial. Arch Gen Psychiatry. 2006;63:1158-1165.
24. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS. Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res. 1996;64:169-178.
25. Keck PE Jr, McElroy SL, Friedman LM. Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes [review]. J Clin Psychopharmacol. 1992;12(1 suppl):36S-41S.
26. Hamner MB, Brodrick PS, Labbate LA. Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy. Ann Clin Psychiatry. 2001;13:141-146.
27. Yehuda R, Siever LJ, Teicher MH, Levengood RA, Gerber DK, Schmeidler J, et al. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in posttraumatic stress disorder and major depressive disorder. Biol Psychiatry. 1998;44:56-63.
28. Pitman RK. Post-traumatic stress disorder, hormones, and memory [review]. Biol Psychiatry. 1989;26:221-223.
29. Kolb LC, Burris BC, Griffiths S. Propranolol and clonidine in the treatment of post-traumatic stress disorders of war. In: Van der Kolb BA, ed. Post-Traumatic Stress Disorder: Psychological and Biological Sequelae. Washington, DC: American Psychiatric Press; 1984:98-105.
30. Kinzie JD. Therapeutic approaches to traumatized Cambodian refugees. J Traumatic Stress. 1989;2:75-91.
31. Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract. 2007;13:72-78.
32. Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo controlled study. Am J Psychiatry. 2003;160:371-373. Available at: http://ajp.psychiatryonline.org/cgi/content/full/160/2/371. Accessed April 13, 2007.
33. Ramaswamy S, Madaan V, Qadri F, Heaney CJ, North TC, Padala PR, et al. A primary care perspective of posttraumatic stress disorder for the Department of Veterans Affairs. Prim Care Companion J Clin Psychiatry. 2005;7:180-187. Available at: http://www.psychiatrist.com/pcc/pccpdf/v07n04/v07n0407.pdf. Accessed April 13, 2007.
34. Hamner M, Ulmer H, Horne D. Buspirone potentiation of antidepressants in the treatment of PTSD. Depress Anxiety. 1997;5:137-139.
35. Newcomer JW. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence [review]. J Clin Psychiatry. 2007;68(suppl 1):20-27.
36. Lande RG, Marin BA, Chang AS, Lande GR. Gender differences and alcohol use in the US Army. J Am Osteopath Assoc. In press.
37. Weisberg RB, Bruce SE, Machan JT, Kessler RC, Culpepper L, Keller MB. Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder. Psychiatr Serv. 2002;53:848-854. Available at: http://ps.psychiatryonline.org/cgi/content/full/53/7/848. Accessed April 13, 2007.
38. Lande RG, Marin BA, Ruzek JI. Substance abuse in the deployment environment. In: Iraq War Clinician Guide. 2nd ed. White River Station, Vt: National Center for Post-Traumatic Stress Disorder, Department of Veterans Affairs; 2004:79-82. Available at: http://www.ncptsd.va.gov/ncmain/ncdocs/ manuals/ iraq_clinician_guide_ch_12.pdf. Accessed April 13, 2007.